Close Menu

NEW YORK (GenomeWeb) – Canopy Biosciences announced today that it has acquired German cytometry startup Zellkraftwerk as part of its plans to build a wider product and service offering.

According to Canopy, the acquisition creates a "unique multi-omics" company that offers "a powerful union of genomic expertise with cutting-edge cell and tissue analysis solutions" to further help "drug development research and biomarker discovery."

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Guardian reports that some UK physicians are calling for increased regulation of direct-to-consumer genetic tests.

US tax agency says 23andMe's genetic health test can be claimed as a medical expense for tax purposes, the Wall Street Journal reports.

Two Democratic lawmakers argue at USA Today that independent science is under attack by the Trump Administration.

In PLOS this week: networks of genes co-expressed in depression, role of minichromosome maintenance genes in lung adenocarcinoma, and more.

Aug
29
Sponsored by
PerkinElmer

This webinar will outline how RUCDR Infinite Biologics, the world's largest university-based biorepository, has implemented workflows and processes to support precision medicine applications.